"It is now clear that substantial and consistent progress has been made by India and overall, Indian laws relating to patents and their application do not deny adequate and effective protection of IPR, nor do they deny fair and equitable market access to the US pharmaceutical industry which relies on ...
Read more: / USTR urged to remove India from Priority Watch List